Jones, L., Affronti, M. L., Bohlin, C. W., Herndon, J. E., Quinn, J. A., Reardon, D. A., … Vredenburgh, J. J. (2007). Prevalence of osteoporosis in glioma patients on enzyme inducing anticonvulsants (EIAC) and/or glucocorticoids. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 25). AMER SOC CLINICAL ONCOLOGY.

Jones, L., M. L. Affronti, C. W. Bohlin, J. E. Herndon, J. A. Quinn, D. A. Reardon, J. N. Rich, H. S. Friedman, and J. J. Vredenburgh. “Prevalence of osteoporosis in glioma patients on enzyme inducing anticonvulsants (EIAC) and/or glucocorticoids.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 25. AMER SOC CLINICAL ONCOLOGY, 2007.

Jones L, Affronti ML, Bohlin CW, Herndon JE, Quinn JA, Reardon DA, et al. Prevalence of osteoporosis in glioma patients on enzyme inducing anticonvulsants (EIAC) and/or glucocorticoids. In: JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2007.

Jones, L., et al. “Prevalence of osteoporosis in glioma patients on enzyme inducing anticonvulsants (EIAC) and/or glucocorticoids.” JOURNAL OF CLINICAL ONCOLOGY, vol. 25, no. 18, AMER SOC CLINICAL ONCOLOGY, 2007.

Jones L, Affronti ML, Bohlin CW, Herndon JE, Quinn JA, Reardon DA, Rich JN, Friedman HS, Vredenburgh JJ. Prevalence of osteoporosis in glioma patients on enzyme inducing anticonvulsants (EIAC) and/or glucocorticoids. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2007.